Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Current API product portfolio   

Metoprolol succinate

Specification:
  • Ph.Eur.
chemical name: (4-amino-1-hydroxybutylidene)bisphosphonic acid monosodium salt trihydrate
molecular formula: C34H56N2O10
structural formula: structural formula
molecular weight: 653
CAS Registery number: 98418-47-4

General information:

Appearance: white, crystalline powder.
Solubility: freely soluble in water, soluble in methanol, slightly soluble in alcohol, very slightly soluble in ethyl acetate.

TESTS REQUIERMENTS METHODS
Idetyfication:

IR spectrum


comparison with reference substance spectrum
Ph. Eur.
Appearance of solution (20mg/ml) solution is not more opalescent than reference suspension II and it is colourless Ph. Eur.
pH of solution (20 mg/ml) 7.0 - 7.6 Ph. Eur.
Related substances:

A. TLC

- single impurity

B. HPLC

- single impurity

- total impurities




not more than 0.2%



not more than 0.1%

not more than 0.5%
Ph. Eur.
Heavy metals not more than 10 ppm Ph. Eur.
Loss on drying not more than 0.5% Ph. Eur.
Sulphated ash not more than 0.1% Ph. Eur.
Content of metoprolol succinate calculated on dried substance 99.0% to 101.0% Ph. Eur.
Residual solvents:

- acetone

- toluene


not more than 2500 ppm

not more than 100 ppm
POLPHARMA
« back to API list

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo